Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Moderna Inc (NQ: MRNA )

85.91 +3.66 (+4.45%)
Streaming Delayed Price Updated: 10:45 AM EDT, Aug 15, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,076,733
Open 83.65
Bid (Size) 85.86 (2)
Ask (Size) 85.95 (2)
Prev. Close 82.25
Today's Range 83.56 - 86.19
52wk Range 62.55 - 170.47
Shares Outstanding 384,000,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MODERNA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Moderna, Inc. and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Stockholder Alert: Robbins LLP Informs Moderna, Inc. Stockholders that a Shareholder Filed a Class Action Against MRNA
From Robbins LLP
Via Business Wire

Performance

YTD
-23.64%
-23.64%
1 Month
-29.28%
-29.28%
3 Month
-33.43%
-33.43%
6 Month
-0.05%
-0.05%
1 Year
-10.89%
-10.89%

More News

Read More
Stockholder Alert: Robbins LLP Informs Moderna, Inc. Stockholders that a Shareholder Filed a Class Action Against MRNA
From Robbins LLP
Via GlobeNewswire
Moderna and Coursera Launch Free Course on mRNA Technology
Via ACCESSWIRE
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
Via Benzinga
Exposures COVID-19
Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
Via Benzinga
Exposures COVID-19
Smart Money Is Betting Big In MRNA Options
Via Benzinga
Market Whales and Their Recent Bets on MRNA Options
Via Benzinga
What the Options Market Tells Us About Moderna
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,300 Today
Via Benzinga
3 Biotech Stocks Poised for a Comeback After Last Week’s Market Meltdown
Via InvestorPlace
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – MRNA
From The Rosen Law Firm PA
Via GlobeNewswire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?
Via MarketBeat
Exposures COVID-19
MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Expanding the Cloud for AI
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Undervalued Stocks With Room to Rally Even Higher
Via InvestorPlace
Moderna Lost 27% Of Its Value Over Two Days. It Just Crumbled Again.
Via Investor's Business Daily
Home Depot To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Monday
Via Benzinga
BioNTech's Q2 Loss Widens Amid Low Demand For Its Pfizer-Partnered COVID-19 Vaccine, Increases R&D Spending On New Cancer Products
Via Benzinga
Exposures COVID-19
MicroStrategy, Intel And Moderna Are Among Top 12 Large Cap Losers Last Week (July 28-August 3): Are The Others In Your Portfolio?
Via Benzinga
Cathie Wood Bought This Stock After Its 27% Drop. Should You?
Via The Motley Fool
Where Will Novavax Be in 5 Years?
Via The Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
   
Privacy Policy  |  Terms of Use  |  MNG Corporate Site Map  |  Copyright